360DigitalInfluence

If you could have put all the people working in marketing at pharmaceutical companies together in a room today, you might have heard a collective sigh of disappointment. As many suspected for weeks or even months now, the FDA quietly confirmed that the long awaited guidelines for how to use social media for which they held a hearing in late 2009 won’t be coming this year and to expect them (perhaps) in Q1 of 2011. Earlier this month, however, the FDA did release a sweeping document that received much less fanfare from marketers - even though the implications of it may change the world of pharmaceutical marketing for the next half decade at least.

That document focused on the FDA’s “Strategic Priorities: 2011 - 2015″ and offers nearly 50 pages of insights into the future direction of the FDA and offers many hidden insights that everyone who is considering doing any marketing or communications for a drug, medical device, healthcare organization or biomedical research organization should pay attention to. Here are a few of the most noteworthy passages in that document along with thoughts from our Ogilvy Digital Healthcare team on their significance.

“FDA’s primary responsibility is to protect the American people from unsafe or mislabeled food, drugs, and other medical products and to make sure consumers have access to accurate, science-based information about the products they need and rely on every day.”

1. What It Means: Despite Lots Of Hope From The Industry, Social Media Guidance Isn’t A Priority For The FDA
There is only one point in the entire 48 page document of strategic priorities where social media is even mentioned, and much of the document focuses on the much bigger challenges and scope of the FDA. When you work in Pharma, you tend to underestimate the scope of the FDA’s mission. As this document spells out, issuing social media guidance is nowhere near a priority for the FDA - and despite what anyone working in this area may want to see happen, it is unlikely that this will change in the near future. continue reading

When SXSW, one of the largest gatherings of minds and enthusiasts in the digital world, didn’t feature more than a handful of panels on the intersection between health and social media - an “unconference” event called SXSH sprung up to fill the void. Yesterday that event came together in Austin and included speakers and pioneers in using social media to communicate for health issues in regional hospitals, government agencies, health insurers, nonprofits, epatients and pharma companies. Just about every part of the healthcare world had some sort of voice in the discussion as everyone gathered to share ideas on how the industry as a whole might use social media more effectively by building greater trust.

The day long discussion featured many highlights, starting with a talk from Doug Ulman, CEO of Livestrong about the power of health based communities online and how important real time information is to improving healthcare and the patient experience. Greg Matthews from Humana shared how a health insurer can innovate internally and use that to improve patient relationships and Jenn Texada from MD Anderson shared how she and her communications team use social media tools to interact directly with patients for customer service. David Hale from the National Library of Medicine presented an innovative new database to help identify unknown pills called Pillbox and Fabio Gratton shared how to build a movement through a case study of the success of the #FDASM movement in November of last year around the FDA hearings. In the “unconference” part of the day, companies such as ReachMD and WEGO Health talked about their communities and content and how they help bridge the gaps between patients, doctors and healthcare providers.
continue reading